MAR 26, 2015 10:13 PM PDT

Why Some HPV Infections Go Away and Others Become Cancer

For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed.

A new study finds that the body's ability to defeat the virus may be largely due to unpredictable division patterns in HPV-infected stem cells, rather than the strength of the person's immune response.

If the mathematical model behind the findings holds up, it could point to ways of tweaking the way infected cells divide in order to make HPV infections go away faster and hence lower the risk of developing cancer, said co-author Marc Ryser of Duke University.

The results appear online in the journal PLOS Computational Biology.

More than six million people in the U.S. become infected with HPV every year. Most people clear the virus on their own in one to two years with little or no symptoms. But in some people the infection persists. The longer HPV persists the more likely it is to lead to cancer, including cancers of the cervix, penis, anus, mouth and throat.

To better understand why some HPV infections go away and others progress, Duke mathematicians Marc Ryser and Rick Durrett developed a model of HPV infection at the level of the infected tissue.

HPV spreads through intimate skin-to-skin contact during sex with an infected person, and takes advantage of the tissue's natural internal repair system to reproduce and spread.

The invading virus breaks through the layers of cells that line the cervix and other tissues and infects the stem cells in the innermost layer, called the basal layer.

Usually, when an infected stem cell divides into two, one of the new cells stays in the basal layer and the other cell is pushed outward into the upper layers where it dies and is sloughed off, releasing virus particles that can then infect another person.

But sometimes, in a process called symmetric division, an infected cell produces two cells with the same fate -- either they both stay in the basal layer or they both make their way to the surface.

The Duke researchers wanted to find out if the balance between these two modes of division affects the number of infected stem cells in the basal layer over time.

By combining their model with data from a population of 313 teenage girls who were tested for HPV every six months for four years, the researchers were able to measure the influence of symmetric and asymmetric cell divisions on the time it takes to get rid of the virus, and compare it to the body's ability to kill virus-infected cells via immune cells called killer T-cells.

Surprisingly, random division patterns in infected cells were found to play a critical role in eradicating the virus.

In particular, the researchers calculated that as much as 83 percent of the body's ability to clear the infection can be explained by the pattern of divisions in HPV-infected cells.

"There is no doubt that the immune system plays a role in HPV clearance," Ryser said. "However, the contribution from the stem cell division patterns may play a non-negligible role in the process, something that has not been acknowledged in previous studies."

The team's next step is to use their model to try to understand why some people who take oral contraceptives for a long time have an increased risk of developing cervical cancer.

Source: Duke University
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
AUG 07, 2018
Cancer
AUG 07, 2018
Potential Bcl-2 Targeted Therapy for Relapsed Multiple Myeloma Patients
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA....
SEP 15, 2018
Clinical & Molecular DX
SEP 15, 2018
Cancer & Anoikis: A Match Not Made in Heaven
Anoikis have always been intimately entwined with cancer, henceforth the quest to seek how they came to be as such....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
DEC 03, 2018
Cancer
DEC 03, 2018
Using bubbly nano-particles for chemotherapy delivery
We have all heard about the harsh side effects of chemotherapy that could be so difficult leading to stopping treatment. The reason behind those side effects is that chemotherapy drugs do tar...
DEC 05, 2018
Cancer
DEC 05, 2018
Zika virus as a weapon against brain cancer
Glioblastoma is the most aggressive type of Brain Cancer with an average survival rate of less than two years with treatment. So what if there could be a cure for this type of cancer....
DEC 05, 2018
Immunology
DEC 05, 2018
Combo-Kick to Battle Lymphoma
Combination immunotherapy has provided remission for patients suffering from Hodgkin's Lymphoma...
Loading Comments...